INS and diabetes mellitus: Compare the protective value of metformin against GLP-1s, insulin, and sulfonylureas for glycated hemoglobin (HbA1c) levels, AD development, and mortality; and compare the protective utility of metformin when used in those with DM compared to when used in those without DM for HbA1c levels, AD development, and mortality.